Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-18T00:25:14.725Z Has data issue: false hasContentIssue false

Potato rhamnogalacturonan I reduces colon cancer cell proliferation via a galectin-3 independent mechanism

Published online by Cambridge University Press:  15 April 2015

E. Maxwell
Affiliation:
Institute of Food Research, Norwich, UK NR4 7UA
V. Morris
Affiliation:
Institute of Food Research, Norwich, UK NR4 7UA
K. Waldron
Affiliation:
Institute of Food Research, Norwich, UK NR4 7UA
N. Belshaw
Affiliation:
Institute of Food Research, Norwich, UK NR4 7UA
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2015 

Modified pectin is known to have anti-metastatic effects in various cancer cell lines but the mechanisms remain unclear(Reference Morris and Belshaw1). Although structurally complex, pectin extracts contain galactan rich regions of rhamnogalacturonan I (RGI), attached to a polygalacturonic acid (PGA) backbone. It has been proposed that galactan chains can bind and inhibit Galectin-3 (Gal3)(Reference Inohara and Raz2), a protein upregulated in cancer cells and known to drive numerous processes in carcinogenesis(Reference Nangia-Makker and Balan3). We previously showed that potato galactan (PG) binds specifically to Gal3, whilst potato RGI showed a lower affinity and PGA did not bind at all(Reference Gunning and Bongaerts4).

In this study we investigated the effects of potato RGI, PG, and PGA on cell proliferation in the colon cancer cell lines DLD1 and HCT116 and determined the role of Gal3 in mediating these effects. Cells were treated with 0·2, 0·5 and 1 mg/ml RGI, PG and PGA (all Megazyme, Ireland) in quadruplicate for 48 h and the effects on cell proliferation were measured using WST cell proliferation reagent (Roche, UK). Five independent experiments were performed. Cell proliferation of both cells lines was significantly reduced in a dose-dependent manner by RGI (Fig.1 p < 0·001), while PG and PGA were ineffective.

Fig. 1. Dose effect

Both cell lines were transfected with 12nM Gal3-specific siRNA's or non-specific control siRNA using Hiperfect transfection reagent according to the manufacturer's instructions (all Qiagen, UK). After 24 h of transfection, cells were supplied with medium with or without RGI (1 mg/ml) for 48 h before analysis of cell proliferation or harvesting for RNA and protein extraction. Gal3 gene expression was quantified by qRT-PCR and protein expression by western blot. Transfection decreased steady-state levels of Gal3 mRNA by 90% and 80% in DLD1 and HCT116 cells, respectively, compared with cells transfected with non-specific, control siRNA. Accordingly, Gal3 protein expression was decreased by 91% and 90%, respectively. The reduction of Gal3 expression in DLD1 and HCT116 cells had no significant impact on the anti-proliferative effect of RGI (Fig. 2 p < 0·001). In conclusion, the present study demonstrates that RGI fragments extracted from potato fibre inhibit proliferation of the colon cancer cell lines DLD1 and HCT116 in a Gal3-independent manner.

Fig. 2. siRNA

This work was supported by the International Pectin Producers Association via a BBSRC CASE studentship

References

1.Morris, VJ, Belshaw, NJ et al. (2013) Bioactive carbs and dietary fibre 1, 3852.Google Scholar
2.Inohara, H, Raz, A (1994) Glycoconj J 11, 527532.Google Scholar
3.Nangia-Makker, P, Balan, V et al. (2012)Methods Mol Biol 878, 251266.Google Scholar
4.Gunning, AP, Bongaerts, RJM et al. (2009) Faseb J 23, 415–42.Google Scholar
Figure 0

Fig. 1. Dose effect

Figure 1

Fig. 2. siRNA